Beta Bionics (BBNX) Cash from Financing Activities (2024 - 2026)
Beta Bionics (BBNX) posted Cash from Financing Activities of $1.8 million for Q2 2026, up 189.09% sequentially from $623000.0 in Q1 2026, and up 4188.1% YoY from $42000.0 in Q2 2025.
Beta Bionics (BBNX) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Beta Bionics has reported Cash from Financing Activities for 3 years, with the latest figure at $1.8 million in Q2 2026.
- Quarterly Cash from Financing Activities rose 4188.1% year-over-year to $1.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.1 million (down 97.7% YoY) and the FY2025 annual result came in at $214.9 million, up 286.36% from the prior year.
- Cash from Financing Activities improved to $1.8 million in Q2 2026 per BBNX's latest filing, from $623000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $211.1 million in Q1 2025 and troughed at -$1.2 million in Q3 2024.
- A 3-year average of $27.3 million and a median of $841500.0 in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities surged 3518550.0% in 2025, then plunged 99.7% in 2026.
- Over 3 years, Cash from Financing Activities stood at $56.9 million in 2024, then plunged by 98.14% to $1.1 million in 2025, then jumped by 69.91% to $1.8 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $1.8 million, $623000.0, and $1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Beta Bionics | 837.45 Mn | 656.96 Mn | 18.90 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.80 Mn |
| Jun 30, 2026 | 1.80 Mn |
| Mar 31, 2026 | 623,000.00 |
| Mar 31, 2026 | 623,000.00 |
| Dec 31, 2025 | 1.06 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Jun 30, 2025 | 42,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Mar 31, 2025 | 211.12 Mn |
| Mar 31, 2025 | 211.12 Mn |
| Dec 31, 2024 | 56.89 Mn |
| Dec 31, 2024 | 56.89 Mn |
| Sep 30, 2024 | -1.18 Mn |
| Sep 30, 2024 | -1.18 Mn |
| Jun 30, 2024 | -107,000.00 |
| Jun 30, 2024 | -107,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |